KR101931792B1 - 심근 관류를 영상화하기 위한 조영제 - Google Patents

심근 관류를 영상화하기 위한 조영제 Download PDF

Info

Publication number
KR101931792B1
KR101931792B1 KR1020147018989A KR20147018989A KR101931792B1 KR 101931792 B1 KR101931792 B1 KR 101931792B1 KR 1020147018989 A KR1020147018989 A KR 1020147018989A KR 20147018989 A KR20147018989 A KR 20147018989A KR 101931792 B1 KR101931792 B1 KR 101931792B1
Authority
KR
South Korea
Prior art keywords
imaging
composition
imaging agent
patient
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147018989A
Other languages
English (en)
Korean (ko)
Other versions
KR20140107411A (ko
Inventor
마르틴 요한손
Original Assignee
레스피라토리우스 아브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 레스피라토리우스 아브 filed Critical 레스피라토리우스 아브
Publication of KR20140107411A publication Critical patent/KR20140107411A/ko
Application granted granted Critical
Publication of KR101931792B1 publication Critical patent/KR101931792B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020147018989A 2011-12-22 2012-12-18 심근 관류를 영상화하기 위한 조영제 Expired - Fee Related KR101931792B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161579113P 2011-12-22 2011-12-22
SE1151249-8 2011-12-22
SE1151249 2011-12-22
US61/579,113 2011-12-22
PCT/SE2012/051421 WO2013095273A1 (en) 2011-12-22 2012-12-18 Contrast agent for imagining myocardial perfusion

Publications (2)

Publication Number Publication Date
KR20140107411A KR20140107411A (ko) 2014-09-04
KR101931792B1 true KR101931792B1 (ko) 2019-03-13

Family

ID=48668967

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147018989A Expired - Fee Related KR101931792B1 (ko) 2011-12-22 2012-12-18 심근 관류를 영상화하기 위한 조영제

Country Status (15)

Country Link
US (2) US9295738B2 (enExample)
EP (1) EP2793952B1 (enExample)
JP (1) JP6140187B2 (enExample)
KR (1) KR101931792B1 (enExample)
CN (1) CN104114191A (enExample)
AU (1) AU2012354223B2 (enExample)
BR (1) BR112014015124A2 (enExample)
CA (1) CA2859773C (enExample)
ES (1) ES2687234T3 (enExample)
IL (1) IL233219A (enExample)
MX (1) MX356258B (enExample)
RU (1) RU2629840C2 (enExample)
SG (1) SG11201403429YA (enExample)
WO (1) WO2013095273A1 (enExample)
ZA (1) ZA201405199B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955876B2 (en) * 2016-09-08 2018-05-01 Raul Chirife Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance
CN107233585B (zh) * 2017-06-09 2021-01-22 四川大学华西医院 黄连素或其衍生物在制备心肌灌注显像剂中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010097410A1 (en) 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US7932272B2 (en) 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010097410A1 (en) 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls

Also Published As

Publication number Publication date
CN104114191A (zh) 2014-10-22
MX356258B (es) 2018-05-16
HK1201459A1 (en) 2015-09-04
US20160101195A1 (en) 2016-04-14
JP2015500873A (ja) 2015-01-08
RU2014125849A (ru) 2016-02-10
US9687565B2 (en) 2017-06-27
IL233219A (en) 2016-08-31
CA2859773A1 (en) 2013-06-27
WO2013095273A1 (en) 2013-06-27
CA2859773C (en) 2020-09-01
ES2687234T3 (es) 2018-10-24
AU2012354223B2 (en) 2017-03-16
EP2793952B1 (en) 2018-06-13
US20140341808A1 (en) 2014-11-20
JP6140187B2 (ja) 2017-05-31
US9295738B2 (en) 2016-03-29
EP2793952A1 (en) 2014-10-29
IL233219A0 (en) 2014-08-31
RU2629840C2 (ru) 2017-09-04
EP2793952A4 (en) 2015-09-09
BR112014015124A2 (pt) 2017-06-13
SG11201403429YA (en) 2014-07-30
KR20140107411A (ko) 2014-09-04
AU2012354223A1 (en) 2014-07-03
MX2014007491A (es) 2015-02-17
ZA201405199B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
CN106977429B (zh) 用于合成和使用造影剂的组合物、方法和系统
RU2641285C2 (ru) Соединения хинина, способ их получения и их медицинское применение
JP6987840B2 (ja) Ｉｄｏ１酵素イメージングのための放射性リガンド
US20240042066A1 (en) Fibroblast activation protein inhibitor
CA3116129A1 (en) Radioligands for imaging the lpa1 receptor
KR20180107243A (ko) 에리불린의 합성에서의 중간체 및 관련된 합성 방법
KR101931792B1 (ko) 심근 관류를 영상화하기 위한 조영제
CA2911307C (en) Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
US20110150767A1 (en) Alpha-substituted and alpha-unsubstituted aromatic amino acid derivatives and compositions thereof for use to treat, diagnose, or monitor a medical condition
HK1201459B (en) Contrast agent for imagining myocardial perfusion
CN102223900A (zh) 用于多巴胺d2受体的成像配体
WO2014184682A1 (en) Radiolabeled gnrh antagonists as pet imaging agents
CN103974947A (zh) 可用于体内成像的5ht1a拮抗剂
CN113387896B (zh) 一种4-（2-氯芳基）喹唑啉-2-酰胺衍生物及其应用
US20250222145A1 (en) Tracer composition for radioactive pet diagnosis, intermediate thereof, and production method thereof
JP6041751B2 (ja) スチリルピリジン誘導体化合物
KR20140117199A (ko) 신규한 벤즈아마이드 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 피부암 진단용 약학적 조성물
HK1241356A1 (en) Compositions, methods and systems for the synthesis and use of imaging agents
JP2014218454A (ja) スチリルピリジン誘導体化合物
HK1182933A (en) Compositions, methods and systems for the synthesis and use of imaging agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20221218

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221218